[HTML][HTML] Long noncoding RNA UCA1 promotes carboplatin resistance in retinoblastoma cells by acting as a ceRNA of miR-206
N Wang, H Fan, S Fu, S Li, B Zhou, Q Jin… - American Journal of …, 2022 - ncbi.nlm.nih.gov
Chemoresistance has become a major obstacle to effective retinoblastoma treatment. The
urothelial cancer-associated gene 1 (UCA1) is commonly considered an oncogene in …
urothelial cancer-associated gene 1 (UCA1) is commonly considered an oncogene in …
Long noncoding RNA UCA1 promotes carboplatin resistance in retinoblastoma cells by acting as a ceRNA of miR-206
N Wang, H Fan, S Fu, S Li, B Zhou… - American journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Chemoresistance has become a major obstacle to effective retinoblastoma treatment. The
urothelial cancer-associated gene 1 (UCA1) is commonly considered an oncogene in …
urothelial cancer-associated gene 1 (UCA1) is commonly considered an oncogene in …
[PDF][PDF] Long noncoding RNA UCA1 promotes carboplatin resistance in retinoblastoma cells by acting as a ceRNA of miR-206
N Wang, H Fan, S Fu, S Li, B Zhou, Q Jin, Z You - e-century.us
Chemoresistance has become a major obstacle to effective retinoblastoma treatment. The
urothelial cancer-associated gene 1 (UCA1) is commonly considered an oncogene in …
urothelial cancer-associated gene 1 (UCA1) is commonly considered an oncogene in …
Long noncoding RNA UCA1 promotes carboplatin resistance in retinoblastoma cells by acting as a ceRNA of miR-206.
N Wang, H Fan, S Fu, S Li, B Zhou, Q Jin… - American Journal of …, 2022 - europepmc.org
Chemoresistance has become a major obstacle to effective retinoblastoma treatment. The
urothelial cancer-associated gene 1 (UCA1) is commonly considered an oncogene in …
urothelial cancer-associated gene 1 (UCA1) is commonly considered an oncogene in …